Bradley Foster & Sargent Inc Edwards Lifesciences Corp Transaction History

Bradley Foster & Sargent Inc

$5.82 Billion
Q3 2024

A detailed history of Bradley Foster & Sargent Inc transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Bradley Foster & Sargent Inc holds 14,844 shares of EW stock, worth $987,422. This represents 0.02% of its overall portfolio holdings.

Number of Shares

14,844

Previous 16,842 11.86%

Holding current value

$987,422

Previous $1.56 Million 37.04%

% of portfolio

0.02%

Previous 0.03%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	SELL	$59.7 - $93.78 $119,280 - $187,372	-1,998 Reduced 11.86%	14,844 $979,000
Q2 2024 Aug 09, 2024	BUY	$84.3 - $94.31 $216,060 - $241,716	2,563 Added 17.95%	16,842 $1.56 Million
Q4 2023 Feb 14, 2024	SELL	$61.71 - $77.76 $118,359 - $149,143	-1,918 Reduced 11.84%	14,279 $1.09 Million
Q2 2023 Aug 08, 2023	SELL	$81.41 - $94.33 $15,142 - $17,545	-186 Reduced 1.14%	16,197 $1.53 Million
Q1 2023 May 08, 2023	SELL	$74.26 - $84.51 $64,680 - $73,608	-871 Reduced 5.05%	16,383 $1.36 Million
Q4 2022 Feb 14, 2023	SELL	$68.3 - $87.44 $120,686 - $154,506	-1,767 Reduced 9.29%	17,254 $1.29 Million
Q3 2022 Nov 14, 2022	SELL	$82.37 - $107.29 $37,066 - $48,280	-450 Reduced 2.31%	19,021 $1.57 Million
Q2 2022 Aug 11, 2022	BUY	$86.5 - $128.27 $102,243 - $151,615	1,182 Added 6.46%	19,471 $1.85 Million
Q1 2022 May 16, 2022	BUY	$101.96 - $128.34 $1.24 Million - $1.56 Million	12,164 Added 198.6%	18,289 $2.15 Million
Q4 2021 Mar 11, 2022	BUY	$106.37 - $130.68 $349,957 - $429,937	3,290 Added 116.05%	6,125 $793,000
Q3 2021 Nov 10, 2021	SELL	$102.91 - $122.75 $185,238 - $220,950	-1,800 Reduced 38.83%	2,835 $321,000
Q2 2021 Aug 19, 2021	BUY	$83.84 - $104.76 $251 - $314	3 Added 0.06%	4,635 $480,000
Q4 2020 Feb 11, 2021	BUY	$71.69 - $91.23 $1,290 - $1,642	18 Added 0.39%	4,632 $423,000
Q3 2020 Oct 26, 2020	BUY	$67.19 - $87.44 $206,676 - $268,965	3,076 Added 200.0%	4,614 $368,000
Q2 2019 Aug 08, 2019	SELL	$55.74 - $64.41 $5,574 - $6,441	-100 Reduced 6.11%	1,538 $284,000
Q3 2018 Oct 31, 2018	SELL	$45.7 - $58.03 $8,683 - $11,025	-190 Reduced 10.39%	1,638 $285,000
Q1 2018 May 07, 2018	BUY	$37.19 - $47.45 $1,413 - $1,803	38 Added 2.12%	1,828 $255,000
Q4 2017 Feb 06, 2018	SELL	$33.79 - $39.39 $3,379 - $3,939	-100 Reduced 5.29%	1,790 $202,000
Q3 2017 Nov 03, 2017	BUY	$36.29 - $38.83 $68,588 - $73,388	1,890	1,890 $207,000

Others Institutions Holding EW

# of Institutions

1,330

Shares Held

457M

Call Options Held

2.76M

Put Options Held

2.09M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.1B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bradley Foster & Sargent Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bradley Foster & Sargent Inc with notifications on news.

Account

Bradley Foster & Sargent Inc Edwards Lifesciences Corp Transaction History